Adenosine monophosphate pretreatment of mice with latent herpes simplex virus type 1 infections significantly reduced the rate of reactivation of latent virus. Adenosine monophosphate pretreatment did not, however, eradicate latent virus.
Recently, presented evidence suggesting that adenosine monophosphate (AMP), a naturally occurring cellular metabolite, is an effective treatment for recurrent herpes simplex virus type 1 (HSV-1) infections in humans. They also suggested that AMP could prevent the establishment of a latent infection and that it may eradicate latent HSV-1 from the central nervous system. We therefore tested AMP for these effects in a mouse model. The mouse ear model described by Hill et al. (4, 5) h These were 59 animals from group III which had been allowed to heal after an initial reactivation with amphetamine.
Compared with group III, tr = 8.62 and P < 0.001. d These were 23 animals from group V which did not develop a recurrent ear infection after initial treatment with AMP plus amphetamine.
"These were 18 animals from group III which had been allowed to heal after an initial reactivation with amphetamine.
/ Compared with group IV, t= 5.99 and P < 0.001. Our results indicate that AMP has prophylactic efficacy against both primary and recurrent HSV-1 infections in mice. Therapeutic trials, i.e., use of the agent after the establishment of a primary or recurrent HSV-1 infection, are currently under way. These results would, however, support the observations of Sklar and Buimovici-Klein (8) on the possible efficacy of AMP treatment of human patients, although they do not support eradication of latent virus as a possible mechanism of AMP action. The actual mechanism of action of AMP is unknown. An attractive hypothesis is that it acts via adenosine, which recently has been widely investigated for its effects on cells of the nervous system (1, 3, 9) . Of several effects described, adenosine binding to specific cell membrane receptors decreased intracellular cyclic AMP levels, thus depressing cellular metabolism (1, 10) . A depressed cellular metabolic rate may render cells harboring latent virus incapable of supporting virus replication. Recently, Schnitzlein and Reichmann (7) have shown that adenosine inhibits replication of vesicular stomatitis virus ribonucleic acid by a mechanism as yet unknown. AMP, in contrast, does not appear to directly inhibit replication of HSV-1 in tissue culture cells (T. North, personal communication). It would thus appear doubtful that AMP has any direct antiviral activity against HSVspecific enzymes, as do arabinosyl adenine (6) and acyclovir (2) 
